Suppr超能文献

2004-2014 年美国按年龄、种族和族裔划分的前列腺癌特定阶段发病率和趋势。

Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.

机构信息

Epidemiology and Applied Research Branch, Division of Cancer and Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA.

Epidemiology and Applied Research Branch, Division of Cancer and Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA; Epidemic Intelligence Service, CDC, Atlanta, GA.

出版信息

Ann Epidemiol. 2018 May;28(5):328-330. doi: 10.1016/j.annepidem.2018.03.001. Epub 2018 Mar 6.

Abstract

PURPOSE

Current literature shows different findings on the contemporary trends of distant-stage prostate cancer incidence, in part, due to low study population coverage and wide age groupings. This study aimed to examine the stage-specific incidence rates and trends of prostate cancer by age (5-year grouping), race, and ethnicity using nationwide cancer registry data.

METHODS

Data on prostate cancer cases came from the 2004-2014 United States Cancer Statistics data set. We calculated stage-specific incidence and 95% confidence intervals by age (5-year age grouping), race, and ethnicity. To measure the changes in rates over time, we calculated annual percentage change (APC).

RESULTS

We identified 2,137,054 incident prostate cancers diagnosed during 2004-2014, with an age-adjusted incidence rate of 453.8 per 100,000. Distant-stage prostate cancer incidence significantly decreased during 2004-2010 (APC = -1.2) and increased during 2010-2014 (APC = 3.3). Significant increases in distant prostate cancer incidence also occurred in men aged older than or equal to 50 years except men aged 65-74 and older than or equal to 85 years, in men with white race (APC = 3.9), and non-Hispanic ethnicity (APC = 3.5).

CONCLUSIONS

Using data representing over 99% of U.S. population, we found that incidence rates of distant-stage prostate cancer significantly increased during 2010-2014 among men in certain ages, in white, and with non-Hispanic ethnicity.

摘要

目的

目前的文献显示,由于研究人群覆盖范围低和年龄分组广泛,当代前列腺癌远处转移阶段发病率的趋势存在不同的结果。本研究旨在使用全国癌症登记数据,通过年龄(5 年分组)、种族和族裔检查前列腺癌的特定分期发病率和趋势。

方法

前列腺癌病例数据来自 2004-2014 年美国癌症统计数据。我们按年龄(5 年年龄分组)、种族和族裔计算了特定分期的发病率和 95%置信区间。为了衡量随时间变化的发病率变化,我们计算了年百分比变化(APC)。

结果

我们确定了 2137054 例在 2004-2014 年间诊断的前列腺癌病例,年龄调整后的发病率为 453.8/100000。2004-2010 年间远处转移前列腺癌的发病率显著下降(APC=-1.2),2010-2014 年间发病率增加(APC=3.3)。除了年龄在 65-74 岁及以上和 85 岁及以上的男性外,年龄在 50 岁及以上的男性、白人男性(APC=3.9)和非西班牙裔男性(APC=3.5)的远处前列腺癌发病率也显著增加。

结论

使用代表超过 99%的美国人口的数据,我们发现 2010-2014 年间,在某些年龄、白人、非西班牙裔人群中,远处转移阶段前列腺癌的发病率显著增加。

相似文献

1
Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.
Ann Epidemiol. 2018 May;28(5):328-330. doi: 10.1016/j.annepidem.2018.03.001. Epub 2018 Mar 6.
2
Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
Prostate. 2021 Oct;81(14):1071-1077. doi: 10.1002/pros.24204. Epub 2021 Jul 28.
3
Trends in Prostate Cancer Incidence and Mortality Rates.
JAMA Netw Open. 2025 Jan 2;8(1):e2456825. doi: 10.1001/jamanetworkopen.2024.56825.
4
Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Eur Urol Focus. 2019 Nov;5(6):1014-1021. doi: 10.1016/j.euf.2018.04.016. Epub 2018 May 4.

引用本文的文献

2
Association between surgery treatment delays and survival outcomes in patients with esophageal cancer in Hebei, China.
Front Oncol. 2024 Oct 28;14:1463517. doi: 10.3389/fonc.2024.1463517. eCollection 2024.
3
DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
Epigenetics. 2024 Dec;19(1):2308920. doi: 10.1080/15592294.2024.2308920. Epub 2024 Mar 25.
4
Defining aggressive prostate cancer: a geospatial perspective.
BMC Cancer. 2023 Aug 14;23(1):754. doi: 10.1186/s12885-023-11281-8.
5
Trends in prostate cancer incidence among Black men in the Caribbean and the United States.
Prostate. 2023 Sep;83(12):1207-1216. doi: 10.1002/pros.24580. Epub 2023 May 27.
7
A Historical Misconception in Clinical Trials of Drugs for Cancer-Age Grouping.
J Pers Med. 2022 Dec 2;12(12):1998. doi: 10.3390/jpm12121998.
8
Increasing aggressive prostate cancer.
Can J Urol. 2022 Dec;29(6):11384-11390.

本文引用的文献

1
Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Eur Urol Focus. 2018 Jan;4(1):121-127. doi: 10.1016/j.euf.2017.10.014. Epub 2017 Nov 20.
2
Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
Eur Urol Focus. 2019 Jan;5(1):77-80. doi: 10.1016/j.euf.2017.04.012. Epub 2017 May 12.
3
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
5
Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):259-63. doi: 10.1158/1055-9965.EPI-15-0723. Epub 2015 Dec 8.
7
Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.
J Am Board Fam Med. 2015 Jul-Aug;28(4):491-3. doi: 10.3122/jabfm.2015.04.150062.
8
Early detection of prostate cancer: AUA Guideline.
J Urol. 2013 Aug;190(2):419-26. doi: 10.1016/j.juro.2013.04.119. Epub 2013 May 6.
10
Declines in prostate cancer incidence after changes in screening recommendations.
Arch Intern Med. 2012 Sep 10;172(16):1267-8. doi: 10.1001/archinternmed.2012.2768.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验